Health

Merck and Moderna Explore Cancer Vaccine Collaboration

Updated 2026-10-15 20:10 UTC 1 source Neutral

Merck and Moderna are planning to pair Keytruda with personalized mRNA vaccines to target tumors, aiming for a more effective cancer treatment strategy.

Coverage timeline — 1 article

STAT News

Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.

2026-10-15 19:58 UTC